This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.
(Nordic Laboratories accept no cost or claims related to any phlebotomy services in the event of sample rejection or failure for any reason. By ordering this, or any test, requiring phlebotomy services, you accept any inherent risk and any associated costs.)
IBS Smart is an ELISA blood test that measures the levels of two antibodies known to be elevated in patients with post-infectious irritable bowel syndrome (IBS).
The two validated IBS biomarkers, anti-CdtB and anti-vinculin, are elevated in a majority of IBS patients with diarrheal symptoms and can diagnose diarrhea-predominant or mixed-type IBS (IBS-D or IBS-M). Anti-CdtB and anti-vinculin are not commonly elevated in patients with constipation-predominant IBS (IBS-C).
This test offers physicians an optimized diagnosis protocol for diarrhea-predominant and mixed-type irritable bowel syndrome (IBS-D and IBS-M), thereby preventing any unnecessary invasive procedures and set a faster path to targeted treatment.
If the patient's IBS Smart results are POSITIVE, the patient has clinical IBS 96-100% of the time.